nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—UGT2B7—Mycophenolic acid—psoriasis	0.0668	0.0907	CbGbCtD
Simvastatin—UGT1A1—Mycophenolic acid—psoriasis	0.0578	0.0784	CbGbCtD
Simvastatin—UGT2B7—Mycophenolate mofetil—psoriasis	0.0373	0.0507	CbGbCtD
Simvastatin—UGT1A1—Mycophenolate mofetil—psoriasis	0.0323	0.0438	CbGbCtD
Simvastatin—CYP2C8—Tazarotene—psoriasis	0.0255	0.0347	CbGbCtD
Simvastatin—CYP3A5—Beclomethasone—psoriasis	0.0247	0.0335	CbGbCtD
Simvastatin—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0223	0.0303	CbGbCtD
Simvastatin—SLCO1A2—Prednisolone—psoriasis	0.02	0.0272	CbGbCtD
Simvastatin—ABCC2—Mycophenolate mofetil—psoriasis	0.0196	0.0266	CbGbCtD
Simvastatin—SLCO1A2—Hydrocortisone—psoriasis	0.019	0.0258	CbGbCtD
Simvastatin—SLCO1A2—Prednisone—psoriasis	0.0189	0.0257	CbGbCtD
Simvastatin—SLCO1A2—Cyclosporine—psoriasis	0.0179	0.0243	CbGbCtD
Simvastatin—SLCO1B1—Cyclosporine—psoriasis	0.0169	0.023	CbGbCtD
Simvastatin—ABCC2—Cyclosporine—psoriasis	0.0149	0.0202	CbGbCtD
Simvastatin—CYP2B6—Cholecalciferol—psoriasis	0.0144	0.0195	CbGbCtD
Simvastatin—SLCO1A2—Dexamethasone—psoriasis	0.0118	0.016	CbGbCtD
Simvastatin—CYP2D6—Hydroxyurea—psoriasis	0.0115	0.0156	CbGbCtD
Simvastatin—CYP2C8—Cholecalciferol—psoriasis	0.0109	0.0148	CbGbCtD
Simvastatin—CYP3A7—Hydrocortisone—psoriasis	0.0105	0.0143	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0105	0.0143	CbGbCtD
Simvastatin—CYP3A7—Cyclosporine—psoriasis	0.00993	0.0135	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00993	0.0135	CbGbCtD
Simvastatin—CYP3A5—Mycophenolate mofetil—psoriasis	0.00983	0.0133	CbGbCtD
Simvastatin—ABCC2—Dexamethasone—psoriasis	0.0098	0.0133	CbGbCtD
Simvastatin—SLCO1A2—Methotrexate—psoriasis	0.0095	0.0129	CbGbCtD
Simvastatin—CYP2C8—Mycophenolate mofetil—psoriasis	0.00945	0.0128	CbGbCtD
Simvastatin—CYP2C19—Cholecalciferol—psoriasis	0.00915	0.0124	CbGbCtD
Simvastatin—SLCO1B1—Methotrexate—psoriasis	0.00896	0.0122	CbGbCtD
Simvastatin—ITGB2—synovial membrane of synovial joint—psoriasis	0.00885	0.551	CbGeAlD
Simvastatin—CYP3A4—Calcitriol—psoriasis	0.00858	0.0116	CbGbCtD
Simvastatin—CYP3A5—Hydrocortisone—psoriasis	0.00789	0.0107	CbGbCtD
Simvastatin—ABCC2—Methotrexate—psoriasis	0.00787	0.0107	CbGbCtD
Simvastatin—CYP2C9—Cholecalciferol—psoriasis	0.00761	0.0103	CbGbCtD
Simvastatin—CYP2C8—Hydrocortisone—psoriasis	0.00759	0.0103	CbGbCtD
Simvastatin—CYP3A5—Cyclosporine—psoriasis	0.00745	0.0101	CbGbCtD
Simvastatin—CYP2C8—Cyclosporine—psoriasis	0.00717	0.00972	CbGbCtD
Simvastatin—CYP2D6—Cholecalciferol—psoriasis	0.00695	0.00944	CbGbCtD
Simvastatin—Lovastatin—ITGAL—psoriasis	0.00673	1	CrCbGaD
Simvastatin—CYP3A4—Methoxsalen—psoriasis	0.00668	0.00906	CbGbCtD
Simvastatin—CYP3A7—Dexamethasone—psoriasis	0.00654	0.00888	CbGbCtD
Simvastatin—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00654	0.00888	CbGbCtD
Simvastatin—ABCB1—Mycophenolate mofetil—psoriasis	0.0064	0.00868	CbGbCtD
Simvastatin—CYP2C19—Prednisone—psoriasis	0.00634	0.0086	CbGbCtD
Simvastatin—CYP2B6—Dexamethasone—psoriasis	0.00623	0.00845	CbGbCtD
Simvastatin—CYP2C19—Cyclosporine—psoriasis	0.00601	0.00816	CbGbCtD
Simvastatin—ABCB1—Betamethasone—psoriasis	0.00549	0.00745	CbGbCtD
Simvastatin—ABCB1—Prednisolone—psoriasis	0.00542	0.00735	CbGbCtD
Simvastatin—ABCB1—Hydrocortisone—psoriasis	0.00514	0.00697	CbGbCtD
Simvastatin—ABCB1—Prednisone—psoriasis	0.00512	0.00694	CbGbCtD
Simvastatin—CYP2C9—Cyclosporine—psoriasis	0.005	0.00678	CbGbCtD
Simvastatin—CYP3A5—Dexamethasone—psoriasis	0.00491	0.00666	CbGbCtD
Simvastatin—ABCB1—Cyclosporine—psoriasis	0.00485	0.00658	CbGbCtD
Simvastatin—CYP2C8—Dexamethasone—psoriasis	0.00472	0.0064	CbGbCtD
Simvastatin—CYP2D6—Cyclosporine—psoriasis	0.00457	0.0062	CbGbCtD
Simvastatin—CYP3A4—Cholecalciferol—psoriasis	0.00442	0.006	CbGbCtD
Simvastatin—ITGB2—endothelium—psoriasis	0.00412	0.256	CbGeAlD
Simvastatin—CYP2C19—Dexamethasone—psoriasis	0.00396	0.00537	CbGbCtD
Simvastatin—CYP3A4—Mycophenolate mofetil—psoriasis	0.00383	0.0052	CbGbCtD
Simvastatin—CYP3A4—Triamcinolone—psoriasis	0.00383	0.0052	CbGbCtD
Simvastatin—CYP2C9—Dexamethasone—psoriasis	0.00329	0.00447	CbGbCtD
Simvastatin—CYP3A4—Betamethasone—psoriasis	0.00329	0.00446	CbGbCtD
Simvastatin—CYP3A4—Prednisolone—psoriasis	0.00325	0.0044	CbGbCtD
Simvastatin—ABCB1—Dexamethasone—psoriasis	0.00319	0.00433	CbGbCtD
Simvastatin—CYP3A4—Hydrocortisone—psoriasis	0.00308	0.00417	CbGbCtD
Simvastatin—CYP3A4—Prednisone—psoriasis	0.00307	0.00416	CbGbCtD
Simvastatin—CYP2D6—Dexamethasone—psoriasis	0.00301	0.00408	CbGbCtD
Simvastatin—CYP3A4—Cyclosporine—psoriasis	0.00291	0.00394	CbGbCtD
Simvastatin—ABCB1—Methotrexate—psoriasis	0.00257	0.00348	CbGbCtD
Simvastatin—CYP3A4—Dexamethasone—psoriasis	0.00191	0.0026	CbGbCtD
Simvastatin—ITGB2—tendon—psoriasis	0.00134	0.0833	CbGeAlD
Simvastatin—HMGCR—skin of body—psoriasis	0.000628	0.0391	CbGeAlD
Simvastatin—HMGCR—tendon—psoriasis	0.000478	0.0298	CbGeAlD
Simvastatin—ABCC2—tendon—psoriasis	0.000347	0.0216	CbGeAlD
Simvastatin—CYP2B6—skin of body—psoriasis	0.000307	0.0191	CbGeAlD
Simvastatin—ITGB2—Adaptive Immune System—REL—psoriasis	0.000203	0.00257	CbGpPWpGaD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.0002	0.00254	CbGpPWpGaD
Simvastatin—UGT2B7—NRF2 pathway—TGFA—psoriasis	0.000198	0.00251	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—ERAP1—psoriasis	0.000197	0.0025	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—HLA-C—psoriasis	0.000194	0.00246	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—TNFAIP3—psoriasis	0.000192	0.00243	CbGpPWpGaD
Simvastatin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000192	0.00243	CbGpPWpGaD
Simvastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00019	0.0024	CbGpPWpGaD
Simvastatin—ITGB2—Toll-Like Receptors Cascades—JUN—psoriasis	0.000189	0.0024	CbGpPWpGaD
Simvastatin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000187	0.00237	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HLA-C—psoriasis	0.000186	0.00236	CbGpPWpGaD
Simvastatin—ITGB2—Toll-Like Receptors Cascades—NFKB1—psoriasis	0.000182	0.00231	CbGpPWpGaD
Simvastatin—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.00018	0.00228	CbGpPWpGaD
Simvastatin—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000177	0.00225	CbGpPWpGaD
Simvastatin—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000176	0.00223	CbGpPWpGaD
Simvastatin—ITGB2—Extracellular matrix organization—ICAM1—psoriasis	0.000174	0.00221	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—DDX58—psoriasis	0.000173	0.0022	CbGpPWpGaD
Simvastatin—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000173	0.0022	CbGpPWpGaD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000173	0.0022	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—HLA-E—psoriasis	0.000161	0.00204	CbGpPWpGaD
Simvastatin—UGT1A1—NRF2 pathway—TGFA—psoriasis	0.000161	0.00204	CbGpPWpGaD
Simvastatin—ABCC2—NRF2 pathway—TGFA—psoriasis	0.000157	0.00199	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HLA-E—psoriasis	0.000155	0.00196	CbGpPWpGaD
Simvastatin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000154	0.00195	CbGpPWpGaD
Simvastatin—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000152	0.00193	CbGpPWpGaD
Simvastatin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000152	0.00192	CbGpPWpGaD
Simvastatin—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.00015	0.0019	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—JUN—psoriasis	0.000149	0.00189	CbGpPWpGaD
Simvastatin—HMGCR—PPARA activates gene expression—PPARG—psoriasis	0.000149	0.00189	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000146	0.00185	CbGpPWpGaD
Simvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	0.000146	0.00185	CbGpPWpGaD
Simvastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000141	0.00179	CbGpPWpGaD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000138	0.00175	CbGpPWpGaD
Simvastatin—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000136	0.00172	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—SOCS1—psoriasis	0.000135	0.00171	CbGpPWpGaD
Simvastatin—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000134	0.0017	CbGpPWpGaD
Simvastatin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000134	0.00169	CbGpPWpGaD
Simvastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000132	0.00167	CbGpPWpGaD
Simvastatin—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000132	0.00167	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—ITGAL—psoriasis	0.000131	0.00167	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—VEGFA—psoriasis	0.00013	0.00165	CbGpPWpGaD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.00013	0.00164	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—SOCS1—psoriasis	0.000129	0.00164	CbGpPWpGaD
Simvastatin—ITGB2—Toll Like Receptor 4 (TLR4) Cascade—IL6—psoriasis	0.000128	0.00163	CbGpPWpGaD
Simvastatin—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000125	0.00158	CbGpPWpGaD
Simvastatin—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000124	0.00157	CbGpPWpGaD
Simvastatin—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000123	0.00156	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—REL—psoriasis	0.000123	0.00156	CbGpPWpGaD
Simvastatin—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000122	0.00155	CbGpPWpGaD
Simvastatin—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000121	0.00154	CbGpPWpGaD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.00012	0.00152	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IFIH1—psoriasis	0.000119	0.00151	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—HLA-B—psoriasis	0.000115	0.00146	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—CD8A—psoriasis	0.000115	0.00145	CbGpPWpGaD
Simvastatin—ITGB2—Toll-Like Receptors Cascades—IL6—psoriasis	0.000114	0.00145	CbGpPWpGaD
Simvastatin—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000114	0.00144	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—HLA-C—psoriasis	0.000113	0.00143	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000113	0.00143	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL13—psoriasis	0.000112	0.00142	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—TNFAIP3—psoriasis	0.000112	0.00142	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HLA-B—psoriasis	0.00011	0.0014	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—NDUFA5—psoriasis	0.000103	0.00131	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000103	0.00131	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—NOS2—psoriasis	0.000103	0.0013	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HLA-A—psoriasis	0.000102	0.0013	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—CRP—psoriasis	0.000101	0.00129	CbGpPWpGaD
Simvastatin—HMGCR—AMPK Signaling—TP53—psoriasis	0.000101	0.00129	CbGpPWpGaD
Simvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	0.000101	0.00127	CbGpPWpGaD
Simvastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.85e-05	0.00125	CbGpPWpGaD
Simvastatin—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	9.73e-05	0.00123	CbGpPWpGaD
Simvastatin—Constipation—Cyclosporine—psoriasis	9.73e-05	0.000603	CcSEcCtD
Simvastatin—Angioedema—Betamethasone—psoriasis	9.67e-05	0.0006	CcSEcCtD
Simvastatin—Angioedema—Dexamethasone—psoriasis	9.67e-05	0.0006	CcSEcCtD
Simvastatin—Decreased appetite—Mycophenolate mofetil—psoriasis	9.65e-05	0.000598	CcSEcCtD
Simvastatin—Anorexia—Hydrocortisone—psoriasis	9.64e-05	0.000598	CcSEcCtD
Simvastatin—Diarrhoea—Mycophenolic acid—psoriasis	9.62e-05	0.000597	CcSEcCtD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.62e-05	0.00122	CbGpPWpGaD
Simvastatin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	9.58e-05	0.000594	CcSEcCtD
Simvastatin—ABCB1—Allograft Rejection—IL12B—psoriasis	9.58e-05	0.00121	CbGpPWpGaD
Simvastatin—Malaise—Dexamethasone—psoriasis	9.55e-05	0.000592	CcSEcCtD
Simvastatin—Malaise—Betamethasone—psoriasis	9.55e-05	0.000592	CcSEcCtD
Simvastatin—Anaphylactic shock—Triamcinolone—psoriasis	9.52e-05	0.00059	CcSEcCtD
Simvastatin—Oedema—Triamcinolone—psoriasis	9.52e-05	0.00059	CcSEcCtD
Simvastatin—Vertigo—Dexamethasone—psoriasis	9.51e-05	0.00059	CcSEcCtD
Simvastatin—Vertigo—Betamethasone—psoriasis	9.51e-05	0.00059	CcSEcCtD
Simvastatin—Constipation—Mycophenolate mofetil—psoriasis	9.49e-05	0.000589	CcSEcCtD
Simvastatin—Pain—Mycophenolate mofetil—psoriasis	9.49e-05	0.000589	CcSEcCtD
Simvastatin—Infection—Triamcinolone—psoriasis	9.46e-05	0.000587	CcSEcCtD
Simvastatin—ITGB2—Immune System—HLA-E—psoriasis	9.38e-05	0.00119	CbGpPWpGaD
Simvastatin—Feeling abnormal—Cyclosporine—psoriasis	9.38e-05	0.000581	CcSEcCtD
Simvastatin—Insomnia—Prednisolone—psoriasis	9.36e-05	0.000581	CcSEcCtD
Simvastatin—Alopecia—Prednisone—psoriasis	9.36e-05	0.00058	CcSEcCtD
Simvastatin—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.35e-05	0.00119	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—HLA-DRB1—psoriasis	9.33e-05	0.00118	CbGpPWpGaD
Simvastatin—Gastrointestinal pain—Cyclosporine—psoriasis	9.3e-05	0.000577	CcSEcCtD
Simvastatin—Dizziness—Mycophenolic acid—psoriasis	9.3e-05	0.000577	CcSEcCtD
Simvastatin—Paraesthesia—Prednisolone—psoriasis	9.3e-05	0.000577	CcSEcCtD
Simvastatin—Mental disorder—Prednisone—psoriasis	9.28e-05	0.000575	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—NFKBIA—psoriasis	9.25e-05	0.00117	CbGpPWpGaD
Simvastatin—Erythema—Prednisone—psoriasis	9.22e-05	0.000572	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	9.21e-05	0.000571	CcSEcCtD
Simvastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.2e-05	0.00117	CbGpPWpGaD
Simvastatin—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.15e-05	0.000567	CcSEcCtD
Simvastatin—Insomnia—Hydrocortisone—psoriasis	9.15e-05	0.000567	CcSEcCtD
Simvastatin—Paraesthesia—Hydrocortisone—psoriasis	9.08e-05	0.000563	CcSEcCtD
Simvastatin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	9.08e-05	0.000563	CcSEcCtD
Simvastatin—Urticaria—Cyclosporine—psoriasis	9.04e-05	0.000561	CcSEcCtD
Simvastatin—Myalgia—Betamethasone—psoriasis	9.01e-05	0.000559	CcSEcCtD
Simvastatin—Myalgia—Dexamethasone—psoriasis	9.01e-05	0.000559	CcSEcCtD
Simvastatin—Body temperature increased—Cyclosporine—psoriasis	8.99e-05	0.000558	CcSEcCtD
Simvastatin—Abdominal pain—Cyclosporine—psoriasis	8.99e-05	0.000558	CcSEcCtD
Simvastatin—Anxiety—Betamethasone—psoriasis	8.98e-05	0.000557	CcSEcCtD
Simvastatin—Anxiety—Dexamethasone—psoriasis	8.98e-05	0.000557	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—ICAM1—psoriasis	8.96e-05	0.00114	CbGpPWpGaD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	8.96e-05	0.00114	CbGpPWpGaD
Simvastatin—Vomiting—Mycophenolic acid—psoriasis	8.94e-05	0.000555	CcSEcCtD
Simvastatin—Discomfort—Dexamethasone—psoriasis	8.9e-05	0.000552	CcSEcCtD
Simvastatin—Discomfort—Betamethasone—psoriasis	8.9e-05	0.000552	CcSEcCtD
Simvastatin—Dyspepsia—Hydrocortisone—psoriasis	8.9e-05	0.000552	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—NFKBIA—psoriasis	8.89e-05	0.00113	CbGpPWpGaD
Simvastatin—Rash—Mycophenolic acid—psoriasis	8.87e-05	0.00055	CcSEcCtD
Simvastatin—Dermatitis—Mycophenolic acid—psoriasis	8.86e-05	0.000549	CcSEcCtD
Simvastatin—Pain—Prednisolone—psoriasis	8.85e-05	0.000549	CcSEcCtD
Simvastatin—Hepatitis—Methotrexate—psoriasis	8.85e-05	0.000549	CcSEcCtD
Simvastatin—Urticaria—Mycophenolate mofetil—psoriasis	8.82e-05	0.000547	CcSEcCtD
Simvastatin—Headache—Mycophenolic acid—psoriasis	8.81e-05	0.000546	CcSEcCtD
Simvastatin—Decreased appetite—Hydrocortisone—psoriasis	8.79e-05	0.000545	CcSEcCtD
Simvastatin—Body temperature increased—Mycophenolate mofetil—psoriasis	8.77e-05	0.000544	CcSEcCtD
Simvastatin—Abdominal pain—Mycophenolate mofetil—psoriasis	8.77e-05	0.000544	CcSEcCtD
Simvastatin—HMGCR—Metabolism—CYP2S1—psoriasis	8.77e-05	0.00111	CbGpPWpGaD
Simvastatin—Gastrointestinal disorder—Hydrocortisone—psoriasis	8.73e-05	0.000541	CcSEcCtD
Simvastatin—Fatigue—Hydrocortisone—psoriasis	8.72e-05	0.000541	CcSEcCtD
Simvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.71e-05	0.0011	CbGpPWpGaD
Simvastatin—Vision blurred—Prednisone—psoriasis	8.69e-05	0.000539	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Triamcinolone—psoriasis	8.68e-05	0.000538	CcSEcCtD
Simvastatin—Pain—Hydrocortisone—psoriasis	8.65e-05	0.000536	CcSEcCtD
Simvastatin—Oedema—Dexamethasone—psoriasis	8.64e-05	0.000536	CcSEcCtD
Simvastatin—Oedema—Betamethasone—psoriasis	8.64e-05	0.000536	CcSEcCtD
Simvastatin—Anaphylactic shock—Dexamethasone—psoriasis	8.64e-05	0.000536	CcSEcCtD
Simvastatin—Anaphylactic shock—Betamethasone—psoriasis	8.64e-05	0.000536	CcSEcCtD
Simvastatin—Insomnia—Triamcinolone—psoriasis	8.61e-05	0.000534	CcSEcCtD
Simvastatin—Infection—Dexamethasone—psoriasis	8.58e-05	0.000532	CcSEcCtD
Simvastatin—Infection—Betamethasone—psoriasis	8.58e-05	0.000532	CcSEcCtD
Simvastatin—Ill-defined disorder—Prednisone—psoriasis	8.55e-05	0.00053	CcSEcCtD
Simvastatin—Paraesthesia—Triamcinolone—psoriasis	8.55e-05	0.00053	CcSEcCtD
Simvastatin—Feeling abnormal—Prednisolone—psoriasis	8.53e-05	0.000529	CcSEcCtD
Simvastatin—Anaemia—Prednisone—psoriasis	8.52e-05	0.000528	CcSEcCtD
Simvastatin—Dyspnoea—Triamcinolone—psoriasis	8.49e-05	0.000526	CcSEcCtD
Simvastatin—Thrombocytopenia—Betamethasone—psoriasis	8.46e-05	0.000525	CcSEcCtD
Simvastatin—Thrombocytopenia—Dexamethasone—psoriasis	8.46e-05	0.000525	CcSEcCtD
Simvastatin—Angioedema—Prednisone—psoriasis	8.42e-05	0.000522	CcSEcCtD
Simvastatin—UGT1A3—Metabolism—NDUFA5—psoriasis	8.41e-05	0.00107	CbGpPWpGaD
Simvastatin—Hypersensitivity—Cyclosporine—psoriasis	8.38e-05	0.00052	CcSEcCtD
Simvastatin—Dyspepsia—Triamcinolone—psoriasis	8.38e-05	0.00052	CcSEcCtD
Simvastatin—Erythema multiforme—Methotrexate—psoriasis	8.37e-05	0.000519	CcSEcCtD
Simvastatin—Nausea—Mycophenolic acid—psoriasis	8.35e-05	0.000518	CcSEcCtD
Simvastatin—Feeling abnormal—Hydrocortisone—psoriasis	8.33e-05	0.000517	CcSEcCtD
Simvastatin—Malaise—Prednisone—psoriasis	8.31e-05	0.000516	CcSEcCtD
Simvastatin—Vertigo—Prednisone—psoriasis	8.28e-05	0.000514	CcSEcCtD
Simvastatin—Gastrointestinal pain—Hydrocortisone—psoriasis	8.27e-05	0.000513	CcSEcCtD
Simvastatin—Anorexia—Dexamethasone—psoriasis	8.24e-05	0.000511	CcSEcCtD
Simvastatin—Anorexia—Betamethasone—psoriasis	8.24e-05	0.000511	CcSEcCtD
Simvastatin—Urticaria—Prednisolone—psoriasis	8.23e-05	0.00051	CcSEcCtD
Simvastatin—Fatigue—Triamcinolone—psoriasis	8.21e-05	0.000509	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—JUN—psoriasis	8.21e-05	0.00104	CbGpPWpGaD
Simvastatin—Hypersensitivity—Mycophenolate mofetil—psoriasis	8.18e-05	0.000507	CcSEcCtD
Simvastatin—Asthenia—Cyclosporine—psoriasis	8.16e-05	0.000506	CcSEcCtD
Simvastatin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	8.16e-05	0.00104	CbGpPWpGaD
Simvastatin—Pain—Triamcinolone—psoriasis	8.14e-05	0.000505	CcSEcCtD
Simvastatin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	8.05e-05	0.00102	CbGpPWpGaD
Simvastatin—Pruritus—Cyclosporine—psoriasis	8.05e-05	0.000499	CcSEcCtD
Simvastatin—Urticaria—Hydrocortisone—psoriasis	8.03e-05	0.000498	CcSEcCtD
Simvastatin—Abdominal pain—Hydrocortisone—psoriasis	7.99e-05	0.000496	CcSEcCtD
Simvastatin—Body temperature increased—Hydrocortisone—psoriasis	7.99e-05	0.000496	CcSEcCtD
Simvastatin—Asthenia—Mycophenolate mofetil—psoriasis	7.96e-05	0.000494	CcSEcCtD
Simvastatin—Chills—Methotrexate—psoriasis	7.94e-05	0.000492	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	7.9e-05	0.001	CbGpPWpGaD
Simvastatin—Musculoskeletal discomfort—Dexamethasone—psoriasis	7.87e-05	0.000488	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Betamethasone—psoriasis	7.87e-05	0.000488	CcSEcCtD
Simvastatin—Pruritus—Mycophenolate mofetil—psoriasis	7.85e-05	0.000487	CcSEcCtD
Simvastatin—Myalgia—Prednisone—psoriasis	7.85e-05	0.000487	CcSEcCtD
Simvastatin—Arthralgia—Prednisone—psoriasis	7.85e-05	0.000487	CcSEcCtD
Simvastatin—Feeling abnormal—Triamcinolone—psoriasis	7.85e-05	0.000487	CcSEcCtD
Simvastatin—ITGB2—Immune System—SOCS1—psoriasis	7.84e-05	0.000994	CbGpPWpGaD
Simvastatin—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	7.83e-05	0.000993	CbGpPWpGaD
Simvastatin—Anxiety—Prednisone—psoriasis	7.82e-05	0.000485	CcSEcCtD
Simvastatin—Alopecia—Methotrexate—psoriasis	7.82e-05	0.000485	CcSEcCtD
Simvastatin—Insomnia—Dexamethasone—psoriasis	7.81e-05	0.000485	CcSEcCtD
Simvastatin—Insomnia—Betamethasone—psoriasis	7.81e-05	0.000485	CcSEcCtD
Simvastatin—Diarrhoea—Cyclosporine—psoriasis	7.79e-05	0.000483	CcSEcCtD
Simvastatin—Paraesthesia—Betamethasone—psoriasis	7.76e-05	0.000481	CcSEcCtD
Simvastatin—Paraesthesia—Dexamethasone—psoriasis	7.76e-05	0.000481	CcSEcCtD
Simvastatin—Discomfort—Prednisone—psoriasis	7.75e-05	0.000481	CcSEcCtD
Simvastatin—Mental disorder—Methotrexate—psoriasis	7.75e-05	0.000481	CcSEcCtD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.74e-05	0.000981	CbGpPWpGaD
Simvastatin—Erythema—Methotrexate—psoriasis	7.7e-05	0.000478	CcSEcCtD
Simvastatin—Hypersensitivity—Prednisolone—psoriasis	7.63e-05	0.000473	CcSEcCtD
Simvastatin—Dyspepsia—Betamethasone—psoriasis	7.61e-05	0.000472	CcSEcCtD
Simvastatin—Dyspepsia—Dexamethasone—psoriasis	7.61e-05	0.000472	CcSEcCtD
Simvastatin—Diarrhoea—Mycophenolate mofetil—psoriasis	7.59e-05	0.000471	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—TYK2—psoriasis	7.58e-05	0.000961	CbGpPWpGaD
Simvastatin—Urticaria—Triamcinolone—psoriasis	7.56e-05	0.000469	CcSEcCtD
Simvastatin—Dysgeusia—Methotrexate—psoriasis	7.54e-05	0.000468	CcSEcCtD
Simvastatin—Body temperature increased—Triamcinolone—psoriasis	7.53e-05	0.000467	CcSEcCtD
Simvastatin—Dizziness—Cyclosporine—psoriasis	7.52e-05	0.000467	CcSEcCtD
Simvastatin—Oedema—Prednisone—psoriasis	7.52e-05	0.000467	CcSEcCtD
Simvastatin—Anaphylactic shock—Prednisone—psoriasis	7.52e-05	0.000467	CcSEcCtD
Simvastatin—Decreased appetite—Dexamethasone—psoriasis	7.51e-05	0.000466	CcSEcCtD
Simvastatin—Decreased appetite—Betamethasone—psoriasis	7.51e-05	0.000466	CcSEcCtD
Simvastatin—Infection—Prednisone—psoriasis	7.47e-05	0.000464	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Betamethasone—psoriasis	7.46e-05	0.000463	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Dexamethasone—psoriasis	7.46e-05	0.000463	CcSEcCtD
Simvastatin—Hypersensitivity—Hydrocortisone—psoriasis	7.45e-05	0.000462	CcSEcCtD
Simvastatin—Fatigue—Betamethasone—psoriasis	7.45e-05	0.000462	CcSEcCtD
Simvastatin—Fatigue—Dexamethasone—psoriasis	7.45e-05	0.000462	CcSEcCtD
Simvastatin—Pain—Dexamethasone—psoriasis	7.39e-05	0.000458	CcSEcCtD
Simvastatin—Pain—Betamethasone—psoriasis	7.39e-05	0.000458	CcSEcCtD
Simvastatin—Dizziness—Mycophenolate mofetil—psoriasis	7.34e-05	0.000455	CcSEcCtD
Simvastatin—Vision blurred—Methotrexate—psoriasis	7.26e-05	0.00045	CcSEcCtD
Simvastatin—Asthenia—Hydrocortisone—psoriasis	7.26e-05	0.00045	CcSEcCtD
Simvastatin—Vomiting—Cyclosporine—psoriasis	7.23e-05	0.000449	CcSEcCtD
Simvastatin—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	7.2e-05	0.000913	CbGpPWpGaD
Simvastatin—Rash—Cyclosporine—psoriasis	7.17e-05	0.000445	CcSEcCtD
Simvastatin—Anorexia—Prednisone—psoriasis	7.17e-05	0.000445	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	7.17e-05	0.000909	CbGpPWpGaD
Simvastatin—Dermatitis—Cyclosporine—psoriasis	7.17e-05	0.000445	CcSEcCtD
Simvastatin—Pruritus—Hydrocortisone—psoriasis	7.15e-05	0.000444	CcSEcCtD
Simvastatin—Ill-defined disorder—Methotrexate—psoriasis	7.15e-05	0.000443	CcSEcCtD
Simvastatin—UGT1A3—Metabolism—CYP2S1—psoriasis	7.15e-05	0.000906	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—NDUFA5—psoriasis	7.15e-05	0.000906	CbGpPWpGaD
Simvastatin—Headache—Cyclosporine—psoriasis	7.13e-05	0.000442	CcSEcCtD
Simvastatin—Anaemia—Methotrexate—psoriasis	7.12e-05	0.000442	CcSEcCtD
Simvastatin—Feeling abnormal—Dexamethasone—psoriasis	7.12e-05	0.000442	CcSEcCtD
Simvastatin—Feeling abnormal—Betamethasone—psoriasis	7.12e-05	0.000442	CcSEcCtD
Simvastatin—Gastrointestinal pain—Betamethasone—psoriasis	7.06e-05	0.000438	CcSEcCtD
Simvastatin—Gastrointestinal pain—Dexamethasone—psoriasis	7.06e-05	0.000438	CcSEcCtD
Simvastatin—Vomiting—Mycophenolate mofetil—psoriasis	7.06e-05	0.000438	CcSEcCtD
Simvastatin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	7.04e-05	0.000893	CbGpPWpGaD
Simvastatin—Hypersensitivity—Triamcinolone—psoriasis	7.02e-05	0.000435	CcSEcCtD
Simvastatin—ABCB1—Allograft Rejection—IL10—psoriasis	7e-05	0.000888	CbGpPWpGaD
Simvastatin—Rash—Mycophenolate mofetil—psoriasis	7e-05	0.000434	CcSEcCtD
Simvastatin—Dermatitis—Mycophenolate mofetil—psoriasis	6.99e-05	0.000434	CcSEcCtD
Simvastatin—Headache—Mycophenolate mofetil—psoriasis	6.95e-05	0.000431	CcSEcCtD
Simvastatin—ITGB2—Immune System—CD8A—psoriasis	6.95e-05	0.000881	CbGpPWpGaD
Simvastatin—Malaise—Methotrexate—psoriasis	6.95e-05	0.000431	CcSEcCtD
Simvastatin—Vertigo—Methotrexate—psoriasis	6.92e-05	0.000429	CcSEcCtD
Simvastatin—Diarrhoea—Hydrocortisone—psoriasis	6.92e-05	0.000429	CcSEcCtD
Simvastatin—Leukopenia—Methotrexate—psoriasis	6.9e-05	0.000428	CcSEcCtD
Simvastatin—Urticaria—Dexamethasone—psoriasis	6.86e-05	0.000426	CcSEcCtD
Simvastatin—Urticaria—Betamethasone—psoriasis	6.86e-05	0.000426	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Prednisone—psoriasis	6.85e-05	0.000425	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—CD4—psoriasis	6.85e-05	0.000869	CbGpPWpGaD
Simvastatin—Dizziness—Prednisolone—psoriasis	6.85e-05	0.000425	CcSEcCtD
Simvastatin—Asthenia—Triamcinolone—psoriasis	6.83e-05	0.000424	CcSEcCtD
Simvastatin—Abdominal pain—Betamethasone—psoriasis	6.83e-05	0.000424	CcSEcCtD
Simvastatin—Body temperature increased—Dexamethasone—psoriasis	6.83e-05	0.000424	CcSEcCtD
Simvastatin—Body temperature increased—Betamethasone—psoriasis	6.83e-05	0.000424	CcSEcCtD
Simvastatin—Abdominal pain—Dexamethasone—psoriasis	6.83e-05	0.000424	CcSEcCtD
Simvastatin—ABCB1—Allograft Rejection—IL4—psoriasis	6.81e-05	0.000864	CbGpPWpGaD
Simvastatin—Insomnia—Prednisone—psoriasis	6.81e-05	0.000422	CcSEcCtD
Simvastatin—Nausea—Cyclosporine—psoriasis	6.76e-05	0.000419	CcSEcCtD
Simvastatin—Paraesthesia—Prednisone—psoriasis	6.76e-05	0.000419	CcSEcCtD
Simvastatin—Pruritus—Triamcinolone—psoriasis	6.74e-05	0.000418	CcSEcCtD
Simvastatin—Dizziness—Hydrocortisone—psoriasis	6.69e-05	0.000415	CcSEcCtD
Simvastatin—ITGB2—Immune System—HLA-B—psoriasis	6.69e-05	0.000848	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.66e-05	0.000845	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.65e-05	0.000844	CbGpPWpGaD
Simvastatin—Dyspepsia—Prednisone—psoriasis	6.62e-05	0.000411	CcSEcCtD
Simvastatin—Nausea—Mycophenolate mofetil—psoriasis	6.59e-05	0.000409	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—CD4—psoriasis	6.58e-05	0.000835	CbGpPWpGaD
Simvastatin—Chest pain—Methotrexate—psoriasis	6.56e-05	0.000407	CcSEcCtD
Simvastatin—Myalgia—Methotrexate—psoriasis	6.56e-05	0.000407	CcSEcCtD
Simvastatin—Arthralgia—Methotrexate—psoriasis	6.56e-05	0.000407	CcSEcCtD
Simvastatin—Decreased appetite—Prednisone—psoriasis	6.54e-05	0.000406	CcSEcCtD
Simvastatin—Rash—Prednisolone—psoriasis	6.53e-05	0.000405	CcSEcCtD
Simvastatin—Dermatitis—Prednisolone—psoriasis	6.52e-05	0.000404	CcSEcCtD
Simvastatin—Fatigue—Prednisone—psoriasis	6.49e-05	0.000402	CcSEcCtD
Simvastatin—Headache—Prednisolone—psoriasis	6.49e-05	0.000402	CcSEcCtD
Simvastatin—Discomfort—Methotrexate—psoriasis	6.48e-05	0.000402	CcSEcCtD
Simvastatin—Constipation—Prednisone—psoriasis	6.43e-05	0.000399	CcSEcCtD
Simvastatin—Vomiting—Hydrocortisone—psoriasis	6.43e-05	0.000399	CcSEcCtD
Simvastatin—Rash—Hydrocortisone—psoriasis	6.38e-05	0.000395	CcSEcCtD
Simvastatin—Dermatitis—Hydrocortisone—psoriasis	6.37e-05	0.000395	CcSEcCtD
Simvastatin—Confusional state—Methotrexate—psoriasis	6.34e-05	0.000393	CcSEcCtD
Simvastatin—Headache—Hydrocortisone—psoriasis	6.34e-05	0.000393	CcSEcCtD
Simvastatin—Dizziness—Triamcinolone—psoriasis	6.3e-05	0.00039	CcSEcCtD
Simvastatin—Anaphylactic shock—Methotrexate—psoriasis	6.29e-05	0.00039	CcSEcCtD
Simvastatin—Infection—Methotrexate—psoriasis	6.25e-05	0.000387	CcSEcCtD
Simvastatin—SLCO1A2—Metabolism—NDUFA5—psoriasis	6.22e-05	0.000789	CbGpPWpGaD
Simvastatin—Feeling abnormal—Prednisone—psoriasis	6.2e-05	0.000385	CcSEcCtD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.2e-05	0.000786	CbGpPWpGaD
Simvastatin—Asthenia—Betamethasone—psoriasis	6.2e-05	0.000384	CcSEcCtD
Simvastatin—Asthenia—Dexamethasone—psoriasis	6.2e-05	0.000384	CcSEcCtD
Simvastatin—ITGB2—Immune System—HLA-A—psoriasis	6.2e-05	0.000786	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.17e-05	0.000783	CbGpPWpGaD
Simvastatin—Thrombocytopenia—Methotrexate—psoriasis	6.16e-05	0.000382	CcSEcCtD
Simvastatin—Gastrointestinal pain—Prednisone—psoriasis	6.15e-05	0.000382	CcSEcCtD
Simvastatin—Nausea—Prednisolone—psoriasis	6.15e-05	0.000381	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—JUN—psoriasis	6.13e-05	0.000778	CbGpPWpGaD
Simvastatin—Pruritus—Betamethasone—psoriasis	6.11e-05	0.000379	CcSEcCtD
Simvastatin—Pruritus—Dexamethasone—psoriasis	6.11e-05	0.000379	CcSEcCtD
Simvastatin—UGT2B7—Metabolism—CYP2S1—psoriasis	6.08e-05	0.000771	CbGpPWpGaD
Simvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.07e-05	0.00077	CbGpPWpGaD
Simvastatin—Vomiting—Triamcinolone—psoriasis	6.05e-05	0.000375	CcSEcCtD
Simvastatin—Nausea—Hydrocortisone—psoriasis	6.01e-05	0.000372	CcSEcCtD
Simvastatin—Rash—Triamcinolone—psoriasis	6e-05	0.000372	CcSEcCtD
Simvastatin—Dermatitis—Triamcinolone—psoriasis	6e-05	0.000372	CcSEcCtD
Simvastatin—Anorexia—Methotrexate—psoriasis	5.99e-05	0.000372	CcSEcCtD
Simvastatin—Urticaria—Prednisone—psoriasis	5.98e-05	0.000371	CcSEcCtD
Simvastatin—Headache—Triamcinolone—psoriasis	5.97e-05	0.00037	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—VEGFA—psoriasis	5.95e-05	0.000755	CbGpPWpGaD
Simvastatin—Abdominal pain—Prednisone—psoriasis	5.95e-05	0.000369	CcSEcCtD
Simvastatin—Body temperature increased—Prednisone—psoriasis	5.95e-05	0.000369	CcSEcCtD
Simvastatin—Diarrhoea—Dexamethasone—psoriasis	5.91e-05	0.000367	CcSEcCtD
Simvastatin—Diarrhoea—Betamethasone—psoriasis	5.91e-05	0.000367	CcSEcCtD
Simvastatin—ITGB2—Immune System—CRP—psoriasis	5.91e-05	0.000749	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—NFKB1—psoriasis	5.91e-05	0.000749	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—NDUFA5—psoriasis	5.81e-05	0.000737	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.8e-05	0.000736	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	5.78e-05	0.000734	CbGpPWpGaD
Simvastatin—Musculoskeletal discomfort—Methotrexate—psoriasis	5.73e-05	0.000355	CcSEcCtD
Simvastatin—Dizziness—Dexamethasone—psoriasis	5.71e-05	0.000354	CcSEcCtD
Simvastatin—Dizziness—Betamethasone—psoriasis	5.71e-05	0.000354	CcSEcCtD
Simvastatin—Insomnia—Methotrexate—psoriasis	5.69e-05	0.000353	CcSEcCtD
Simvastatin—ITGB2—Adaptive Immune System—NFKB1—psoriasis	5.67e-05	0.000719	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—HLA-DRB1—psoriasis	5.66e-05	0.000718	CbGpPWpGaD
Simvastatin—Nausea—Triamcinolone—psoriasis	5.66e-05	0.000351	CcSEcCtD
Simvastatin—Paraesthesia—Methotrexate—psoriasis	5.65e-05	0.00035	CcSEcCtD
Simvastatin—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.64e-05	0.000715	CbGpPWpGaD
Simvastatin—Dyspnoea—Methotrexate—psoriasis	5.61e-05	0.000348	CcSEcCtD
Simvastatin—Hypersensitivity—Prednisone—psoriasis	5.54e-05	0.000344	CcSEcCtD
Simvastatin—Dyspepsia—Methotrexate—psoriasis	5.54e-05	0.000343	CcSEcCtD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	5.52e-05	0.0007	CbGpPWpGaD
Simvastatin—Vomiting—Dexamethasone—psoriasis	5.49e-05	0.000341	CcSEcCtD
Simvastatin—Vomiting—Betamethasone—psoriasis	5.49e-05	0.000341	CcSEcCtD
Simvastatin—Decreased appetite—Methotrexate—psoriasis	5.47e-05	0.000339	CcSEcCtD
Simvastatin—Rash—Dexamethasone—psoriasis	5.45e-05	0.000338	CcSEcCtD
Simvastatin—Rash—Betamethasone—psoriasis	5.45e-05	0.000338	CcSEcCtD
Simvastatin—Dermatitis—Dexamethasone—psoriasis	5.44e-05	0.000338	CcSEcCtD
Simvastatin—Dermatitis—Betamethasone—psoriasis	5.44e-05	0.000338	CcSEcCtD
Simvastatin—ITGB2—Immune System—ICAM1—psoriasis	5.43e-05	0.000689	CbGpPWpGaD
Simvastatin—Gastrointestinal disorder—Methotrexate—psoriasis	5.43e-05	0.000337	CcSEcCtD
Simvastatin—Fatigue—Methotrexate—psoriasis	5.42e-05	0.000336	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—psoriasis	5.42e-05	0.000687	CbGpPWpGaD
Simvastatin—Headache—Betamethasone—psoriasis	5.41e-05	0.000336	CcSEcCtD
Simvastatin—Headache—Dexamethasone—psoriasis	5.41e-05	0.000336	CcSEcCtD
Simvastatin—Asthenia—Prednisone—psoriasis	5.4e-05	0.000335	CcSEcCtD
Simvastatin—ITGB2—Immune System—NFKBIA—psoriasis	5.39e-05	0.000683	CbGpPWpGaD
Simvastatin—Pain—Methotrexate—psoriasis	5.38e-05	0.000333	CcSEcCtD
Simvastatin—Pruritus—Prednisone—psoriasis	5.32e-05	0.00033	CcSEcCtD
Simvastatin—SLCO1B1—Metabolism—NDUFA5—psoriasis	5.32e-05	0.000675	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CYP2S1—psoriasis	5.29e-05	0.000671	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—CP—psoriasis	5.27e-05	0.000668	CbGpPWpGaD
Simvastatin—Feeling abnormal—Methotrexate—psoriasis	5.18e-05	0.000321	CcSEcCtD
Simvastatin—Diarrhoea—Prednisone—psoriasis	5.15e-05	0.000319	CcSEcCtD
Simvastatin—Gastrointestinal pain—Methotrexate—psoriasis	5.14e-05	0.000319	CcSEcCtD
Simvastatin—Nausea—Dexamethasone—psoriasis	5.13e-05	0.000318	CcSEcCtD
Simvastatin—Nausea—Betamethasone—psoriasis	5.13e-05	0.000318	CcSEcCtD
Simvastatin—ABCC2—Transmembrane transport of small molecules—CARM1—psoriasis	5.02e-05	0.000637	CbGpPWpGaD
Simvastatin—Urticaria—Methotrexate—psoriasis	5e-05	0.00031	CcSEcCtD
Simvastatin—Dizziness—Prednisone—psoriasis	4.98e-05	0.000309	CcSEcCtD
Simvastatin—Abdominal pain—Methotrexate—psoriasis	4.97e-05	0.000308	CcSEcCtD
Simvastatin—Body temperature increased—Methotrexate—psoriasis	4.97e-05	0.000308	CcSEcCtD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.96e-05	0.000629	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	4.95e-05	0.000627	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CYP2S1—psoriasis	4.94e-05	0.000626	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—NDUFA5—psoriasis	4.89e-05	0.000619	CbGpPWpGaD
Simvastatin—Vomiting—Prednisone—psoriasis	4.78e-05	0.000297	CcSEcCtD
Simvastatin—Rash—Prednisone—psoriasis	4.74e-05	0.000294	CcSEcCtD
Simvastatin—Dermatitis—Prednisone—psoriasis	4.74e-05	0.000294	CcSEcCtD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	4.72e-05	0.000598	CbGpPWpGaD
Simvastatin—Headache—Prednisone—psoriasis	4.71e-05	0.000292	CcSEcCtD
Simvastatin—Hypersensitivity—Methotrexate—psoriasis	4.63e-05	0.000287	CcSEcCtD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.6e-05	0.000583	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CYP2S1—psoriasis	4.53e-05	0.000574	CbGpPWpGaD
Simvastatin—Asthenia—Methotrexate—psoriasis	4.51e-05	0.00028	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—TP53—psoriasis	4.5e-05	0.00057	CbGpPWpGaD
Simvastatin—Nausea—Prednisone—psoriasis	4.47e-05	0.000277	CcSEcCtD
Simvastatin—Pruritus—Methotrexate—psoriasis	4.45e-05	0.000276	CcSEcCtD
Simvastatin—ITGB2—Immune System—TYK2—psoriasis	4.41e-05	0.00056	CbGpPWpGaD
Simvastatin—Diarrhoea—Methotrexate—psoriasis	4.3e-05	0.000267	CcSEcCtD
Simvastatin—HMGCR—Metabolism—CARM1—psoriasis	4.28e-05	0.000543	CbGpPWpGaD
Simvastatin—Dizziness—Methotrexate—psoriasis	4.16e-05	0.000258	CcSEcCtD
Simvastatin—CYP3A7—Metabolism—CYP2S1—psoriasis	4.15e-05	0.000527	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IFNG—psoriasis	4.13e-05	0.000524	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IFNG—psoriasis	4.12e-05	0.000522	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.11e-05	0.000521	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4e-05	0.000508	CbGpPWpGaD
Simvastatin—Vomiting—Methotrexate—psoriasis	4e-05	0.000248	CcSEcCtD
Simvastatin—ITGB2—Immune System—CD4—psoriasis	3.99e-05	0.000506	CbGpPWpGaD
Simvastatin—Rash—Methotrexate—psoriasis	3.96e-05	0.000246	CcSEcCtD
Simvastatin—Dermatitis—Methotrexate—psoriasis	3.96e-05	0.000246	CcSEcCtD
Simvastatin—Headache—Methotrexate—psoriasis	3.94e-05	0.000244	CcSEcCtD
Simvastatin—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.83e-05	0.000486	CbGpPWpGaD
Simvastatin—Nausea—Methotrexate—psoriasis	3.74e-05	0.000232	CcSEcCtD
Simvastatin—ITGB2—Innate Immune System—IL6—psoriasis	3.71e-05	0.00047	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—NDUFA5—psoriasis	3.61e-05	0.000458	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.59e-05	0.000455	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—JUN—psoriasis	3.57e-05	0.000453	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—NDUFA5—psoriasis	3.53e-05	0.000448	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—CARM1—psoriasis	3.49e-05	0.000443	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—NFKB1—psoriasis	3.44e-05	0.000436	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.15e-05	0.0004	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.11e-05	0.000394	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—STAT3—psoriasis	3.09e-05	0.000392	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CYP2S1—psoriasis	3.07e-05	0.00039	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—NDUFA5—psoriasis	3.06e-05	0.000388	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CYP2S1—psoriasis	3e-05	0.000381	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CARM1—psoriasis	2.97e-05	0.000376	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.85e-05	0.000362	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.77e-05	0.000352	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—NDUFA5—psoriasis	2.73e-05	0.000346	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—TNF—psoriasis	2.67e-05	0.000338	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—NDUFA5—psoriasis	2.66e-05	0.000338	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.65e-05	0.000336	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—CAT—psoriasis	2.63e-05	0.000334	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CYP2S1—psoriasis	2.6e-05	0.00033	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CARM1—psoriasis	2.58e-05	0.000328	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.55e-05	0.000323	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—NDUFA5—psoriasis	2.51e-05	0.000318	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—NDUFA5—psoriasis	2.49e-05	0.000316	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.48e-05	0.000314	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.42e-05	0.000306	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CARM1—psoriasis	2.41e-05	0.000306	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.37e-05	0.000301	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.36e-05	0.0003	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP2S1—psoriasis	2.32e-05	0.000294	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.32e-05	0.000294	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP2S1—psoriasis	2.27e-05	0.000287	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CARM1—psoriasis	2.21e-05	0.00028	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IL6—psoriasis	2.16e-05	0.000274	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—CAT—psoriasis	2.15e-05	0.000272	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP2S1—psoriasis	2.14e-05	0.000271	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP2S1—psoriasis	2.12e-05	0.000268	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.07e-05	0.000262	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—APOE—psoriasis	2.05e-05	0.00026	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CARM1—psoriasis	2.03e-05	0.000257	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CAT—psoriasis	1.83e-05	0.000232	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PPARG—psoriasis	1.78e-05	0.000226	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.76e-05	0.000223	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.69e-05	0.000214	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—APOE—psoriasis	1.67e-05	0.000212	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NDUFA5—psoriasis	1.64e-05	0.000208	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CAT—psoriasis	1.59e-05	0.000202	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.53e-05	0.000195	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CARM1—psoriasis	1.5e-05	0.00019	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CAT—psoriasis	1.48e-05	0.000188	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CARM1—psoriasis	1.47e-05	0.000186	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PPARG—psoriasis	1.45e-05	0.000184	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—APOE—psoriasis	1.42e-05	0.00018	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP2S1—psoriasis	1.4e-05	0.000177	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.36e-05	0.000173	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CAT—psoriasis	1.36e-05	0.000172	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.32e-05	0.000167	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CARM1—psoriasis	1.27e-05	0.000161	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CAT—psoriasis	1.25e-05	0.000158	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PPARG—psoriasis	1.24e-05	0.000157	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—APOE—psoriasis	1.24e-05	0.000157	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.22e-05	0.000154	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.19e-05	0.000151	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.16e-05	0.000147	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—APOE—psoriasis	1.15e-05	0.000146	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CARM1—psoriasis	1.13e-05	0.000144	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.11e-05	0.000141	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CARM1—psoriasis	1.11e-05	0.00014	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PPARG—psoriasis	1.08e-05	0.000136	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.06e-05	0.000134	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—APOE—psoriasis	1.06e-05	0.000134	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CARM1—psoriasis	1.04e-05	0.000132	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CARM1—psoriasis	1.03e-05	0.000131	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PPARG—psoriasis	1e-05	0.000127	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—APOE—psoriasis	9.69e-06	0.000123	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.66e-06	0.000123	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CAT—psoriasis	9.23e-06	0.000117	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PPARG—psoriasis	9.2e-06	0.000117	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CAT—psoriasis	9.02e-06	0.000114	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PPARG—psoriasis	8.44e-06	0.000107	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CAT—psoriasis	7.81e-06	9.91e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—APOE—psoriasis	7.17e-06	9.09e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—APOE—psoriasis	7.01e-06	8.89e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CAT—psoriasis	6.97e-06	8.84e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CARM1—psoriasis	6.82e-06	8.64e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CAT—psoriasis	6.81e-06	8.63e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CAT—psoriasis	6.41e-06	8.13e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CAT—psoriasis	6.36e-06	8.06e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PPARG—psoriasis	6.24e-06	7.92e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PPARG—psoriasis	6.1e-06	7.74e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—APOE—psoriasis	6.07e-06	7.7e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—APOE—psoriasis	5.42e-06	6.87e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—APOE—psoriasis	5.29e-06	6.71e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PPARG—psoriasis	5.29e-06	6.7e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—APOE—psoriasis	4.98e-06	6.32e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—APOE—psoriasis	4.94e-06	6.26e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PPARG—psoriasis	4.72e-06	5.98e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PPARG—psoriasis	4.61e-06	5.84e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PPARG—psoriasis	4.34e-06	5.5e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PPARG—psoriasis	4.3e-06	5.46e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CAT—psoriasis	4.19e-06	5.32e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—APOE—psoriasis	3.26e-06	4.13e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PPARG—psoriasis	2.84e-06	3.6e-05	CbGpPWpGaD
